Echo Street Capital Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Echo Street Capital Management’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-27,770	Closed	-$23K	–	713
2022 Q3	$23K	Hold	27,770	–	–	﹤0.01%	508
2022 Q2	$2K	Hold	27,770	–	–	﹤0.01%	542
2022 Q1	$6K	Hold	27,770	–	–	﹤0.01%	595
2021 Q4	$16K	Hold	27,770	–	–	﹤0.01%	598
2021 Q3	$17K	Hold	27,770	–	–	﹤0.01%	611
2021 Q2	$31K	Hold	27,770	–	–	﹤0.01%	572
2021 Q1	$25K	Buy	+27,770	New	+$47K	﹤0.01%	501

Echo Street Capital Management's FLACW Position: Q4 2022 in Review

Echo Street Capital Management sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 27,770 shares — an estimated $23K sold.

Echo Street Capital Management first reported a position in FLACW in Q1 2021 and held it in 7 quarters. The position peaked at $31K in Q2 2021. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Echo Street Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Echo Street Capital Management sold 27,770 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $23K.
Echo Street Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 7 quarters.
Echo Street Capital Management's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $31K in Q2 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Echo Street Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.